New studies reveal that the treatment of type 2 diabetes goes far beyond merely lowering blood sugar levels.
Remission Possible Even for Normal-Weight Individuals
Even those who are normal weight at diagnosis can normalize their metabolism through significant weight loss. The focus is on relieving metabolic stress. A practical guideline in professional circles is to consider one’s pants size from early adulthood, which defines the optimal waist circumference.
A meta-analysis of long-term cohort studies emphasizes the value of early intervention: reversing prediabetes can reduce the risk of cardiovascular mortality or heart failure by a staggering 58%. These effects can last for decades.
New Medications Expanding Treatment Options
In addition to the well-known Semaglutide, which reduces appetite by increasing satiety and slowing gastric emptying, new substances are entering the market. Retatrutide, a so-called triple agonist, targets GLP-1, GIP, and glucagon receptors. Phase III studies demonstrate significant weight reduction and improved metabolic markers.
At the end of June 2026, the Annals of Internal Medicine published a Phase 2b study on Bofanglutide. This drug is administered only every two weeks. In a study involving 272 participants, it significantly lowered HbA1c levels over 24 weeks while also reducing body weight.
Modern medications can support therapy, but many individuals seek ways to regulate their blood sugar naturally through targeted exercise. In a free guide, you can learn how simple 3-minute exercises can effectively improve your HbA1c levels. Download 7 Simple Exercises to Lower Blood Sugar for Free
However, experts warn that these medications do not replace a healthy lifestyle. They are supportive tools in the treatment of chronic obesity—there is no miracle cure.
Aligning Risks, But Not for Everyone
A comprehensive study in The Lancet, based on data from nearly a million people across seven industrialized nations (1990 to 2024), shows a reduction in cardiovascular risks. Thanks to statins and blood pressure medications, individuals with obesity today have blood pressure and LDL cholesterol levels on par with normal-weight individuals. Older patients particularly benefit from this.
The downside: Young adults with obesity remain a high-risk group. For them, pharmacological prevention has been less effective so far.
Life-style changes have the potential to reduce medication dependence, as demonstrated in a study involving 650 type 2 diabetics. Approximately 6.3% of participants were able to reduce or eliminate their medication, especially Metformin and insulin.
New Definition: BMI Is Not Everything
The medical classification of overweight is evolving. Since 2025, waist circumference will increasingly influence the definition of clinical obesity—not just Body Mass Index (BMI). This has tangible consequences: one-quarter of people with a normal BMI (18.5 to 25) already meet criteria for obesity under the new guidelines.
On a molecular level, researchers at the Weizmann Institute discovered a protein named MTCH2 (“Mitch”). This protein regulates mitochondrial fusion. When disabled in human cells, fat burning increases while the formation of new fat cells is prevented. Animal studies showed improved endurance and a reduction in body fat—without loss of muscle mass. This presents a promising target for future therapies.
While research on new proteins is ongoing, nutrition remains the most vital tool for type 2 diabetics in everyday life. A concerned doctor shares his 6 Golden Rules, showing how you can manage your levels with tasty recipes without sacrificing enjoyment. Free Guide: Eat Deliciously and Control Blood Sugar
Nutrition: Effective, but Not Sustainable
At the ADA Scientific Sessions 2026, a study involving 194 participants showcased the effect of medically tailored meals (MTM) combined with lifestyle counseling. After six months, the HbA1c levels in the intervention group dropped significantly compared to the control group (7.74% vs. 8.17%). Blood pressure also improved significantly.
However, the data also showed that after one year without ongoing intervention, the benefits disappeared.
Meta-analyses have explored the impact of okra powder or extract on cholesterol and blood sugar levels. The findings indicate slight improvements. However, the authors emphasize that such approaches cannot replace pharmacological therapy.
